DOCK2 Human Pre-designed siRNA Set A contains three designed siRNAs for DOCK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOCK3 Human Pre-designed siRNA Set A contains three designed siRNAs for DOCK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOCK4 Human Pre-designed siRNA Set A contains three designed siRNAs for DOCK4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOCK5 Human Pre-designed siRNA Set A contains three designed siRNAs for DOCK5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOCK6 Human Pre-designed siRNA Set A contains three designed siRNAs for DOCK6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOCK7 Human Pre-designed siRNA Set A contains three designed siRNAs for DOCK7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOCK8 Human Pre-designed siRNA Set A contains three designed siRNAs for DOCK8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOCK9 Human Pre-designed siRNA Set A contains three designed siRNAs for DOCK9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Docosahexaenoyl serotonin (DHA-5-HT) is an endogenous n-3 fatty acid-serotonin conjugate. Docosahexaenoyl serotonin is an inhibitor of IL-17. Docosahexaenoyl serotonin has anti-inflammatory activity[1][2].

Dodeca-2E,4E,8Z,10Z/E-N-tetraenoic acid isobutylamide is a brain-penetrant substance and the main alkamide in Echinacea preparations, which might be used for research of common cold and various upper respiratory infections[1].

Dodecane-1,12-diol (Dodecamethylene glycol) is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

Dofetilide (Standard) is the analytical standard of Dofetilide. This product is intended for research and analytical applications. Dofetilide (UK 68789), as a class III antiarrhythmic agent, is an orally active, potent and specific IKr blocker. Dofetilide can be used for the research of cardiovascular disease[1][2].

DOG-IM4 can be used to synthesize nanoparticles to deliver antigen-encoding nucleic acids. It could be used to try to target autoimmune diseases, rare blood or metabolic diseases, allergies, cancer or infectious diseases[1].

DOHH Human Pre-designed siRNA Set A contains three designed siRNAs for DOHH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOK1 Human Pre-designed siRNA Set A contains three designed siRNAs for DOK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOK2 Human Pre-designed siRNA Set A contains three designed siRNAs for DOK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOK3 Human Pre-designed siRNA Set A contains three designed siRNAs for DOK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOK4 Human Pre-designed siRNA Set A contains three designed siRNAs for DOK4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOK5 Human Pre-designed siRNA Set A contains three designed siRNAs for DOK5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOK6 Human Pre-designed siRNA Set A contains three designed siRNAs for DOK6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOK7 Human Pre-designed siRNA Set A contains three designed siRNAs for DOK7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Dolasetron-d5 is deuterated labeled Dolasetron (HY-B0750). Dolasetron (MDL-73147) is a 5-HT3 receptor antagonist with potential for treatment of chemotherapy-induced nausea and vomiting.

DOLK Human Pre-designed siRNA Set A contains three designed siRNAs for DOLK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Donepezil (Standard) is the analytical standard of Donepezil. This product is intended for research and analytical applications. Donepezil (E2020 free base) is a specific and potent AChE inhibitor with IC50s of 8.12 nM and 11.6 nM for bovine AChE and human AChE, respectively[1].

DONSON Human Pre-designed siRNA Set A contains three designed siRNAs for DONSON gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Dopamine D2 receptor agonist-3 (compound 3) is a selective D2 receptor partial agonist and Dopamine D3 receptor antagonist (with pEC50 of 8.3 and

Dopamine D2 receptor agonist-3 (compound 3) is a selective D2 receptor partial agonist and Dopamine D3 receptor antagonist (with pEC50 of 8.3 and

Dopamine D2 receptor agonist-3 (compound 3) is a selective D2 receptor partial agonist and Dopamine D3 receptor antagonist (with pEC50 of 8.3 and

Dopamine D2 receptor agonist-3 (compound 3) is a selective D2 receptor partial agonist and Dopamine D3 receptor antagonist (with pEC50 of 8.3 and

Dopamine D2 receptor agonist-3 (compound 3) is a selective D2 receptor partial agonist and Dopamine D3 receptor antagonist (with pEC50 of 8.3 and

DORI is a cationic lipid that can deliver plasmid DNA in vitro. DORI has lower cytotoxicity and high transfection efficiency[1].

Dorzolamide-d3 hydrochloride is deuterated labeled Dorzolamide hydrochloride (HY-B0109A). Dorzolamide (L671152) hydrochloride is a potent carbonic anhydrase II inhibitor, with IC50 values of 0.18 nM and 600 nM for red blood cell CA-II and CA-I respectively. Dorzolamide possesses anti-tumor activity[1].

DOT1L Human Pre-designed siRNA Set A contains three designed siRNAs for DOT1L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Dot1l Mouse Pre-designed siRNA Set A contains three designed siRNAs for Dot1l gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Dot1l Rat Pre-designed siRNA Set A contains three designed siRNAs for Dot1l gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOTA-4AMPis a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. DOTA-4AMP can be used for conjugation of peptides and radionuclides.

DOTA-amideis a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. DOTA-amide can be used for conjugation of peptides and radionuclides.

DOTA-amideis a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. DOTA-amide can be used for conjugation of peptides and radionuclides.

DOTA-amideis a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. DOTA-amide can be used for conjugation of peptides and radionuclides.

DOTA-amide (dihydrate) is a Bifunctional Chelators (BFCs). DOTA-amide (dihydrate) binds to the Affibody molecule ZHER2:S1. Its complex binds specifically to HER2 and can be used to detect bone metastases, which are common in prostate cancer[1].

DOTA-GA-maleimide is a macrocyclic chelator, which forms stable complex with metals. DOTA-GA-maleimide is utilized as radiolabelled imaging agent[1].

DOTA-GA-maleimide is a macrocyclic chelator, which forms stable complex with metals. DOTA-GA-maleimide is utilized as radiolabelled imaging agent[1].

DOTA-GA-maleimide is a macrocyclic chelator, which forms stable complex with metals. DOTA-GA-maleimide is utilized as radiolabelled imaging agent[1].

DOTA-GA-maleimide is a macrocyclic chelator, which forms stable complex with metals. DOTA-GA-maleimide is utilized as radiolabelled imaging agent[1].